Mergers and Acquisitions

Back to the drawing board: what does Unilever do now?

By and 2022-01-21T09:37:00

GSK VIEW WALL MD

Its £50bn bid for GSK’s consumer healthcare business rejected, can Unilever’s under-pressure management restore City trust?

Already have an account? Sign in here

Want access to this article?

Register for LIMITED access

REGISTER FOR FREE

Get PREMIUM access for £1 a week

SUBSCRIBE NOW